Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
ADVERTISEMENT FEATUREAdvertiser retains sole responsibility for the content of this article
Harnessing the power of nucleic acids to treat cancer
Exicure is pioneering the development of spherical nucleic acid technology as a promising avenue of therapeutic development to strengthen and prolong the body’s natural immune defenses against a wide range of cancers.